Evidence map›Paper›PMID 30521847›Full record

ArticleMethods (San Diego, Calif.)2019

Engineered viral RNA decay intermediates to assess XRN1-mediated decay.

Joseph Russo, Cary T Mundell, Phillida A Charley, Carol Wilusz, Jeffrey Wilusz

Abstract read
In one paragraph

Article in Methods (San Diego, Calif.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Joseph RussoDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80525, United States.
Cary T MundellDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80525, United States; Program in Cell & Molecular Biology, Colorado State University, Fort Collins, CO 80525, United States.
Phillida A CharleyDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80525, United States.
Carol WiluszDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80525, United States; Program in Cell & Molecular Biology, Colorado State University, Fort Collins, CO 80525, United States.
Jeffrey WiluszDepartment of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, CO 80525, United States; Program in Cell & Molecular Biology, Colorado State University, Fort Collins, CO 80525, United States. Electronic address: jeffrey.wilusz@colostate.edu.
Colorado State University · US

Funding

Mechanism of Regulation of mRNA StabilityR01GM072481 · NIGMS · COLORADO STATE UNIVERSITY-FORT COLLINS · PI WILUSZ, JEFFREY · 2004 to 2011
$2.7M
Flavivirus non-coding RNAs and the Host mRNA Decay MachineryR01AI123136 · NIAID · COLORADO STATE UNIVERSITY · PI WILUSZ, JEFFREY · 2016 to 2020
$1.9M
Pathological Implications of Repression of Cellular RNA Decay by Zika VirusR21AI130497 · NIAID · COLORADO STATE UNIVERSITY · PI WILUSZ, JEFFREY · 2017 to 2018
$408k
NIAID NIH HHS R01 AI123136NIAID NIH HHS R21 AI130497NIGMS NIH HHS R01 GM072481
6 · The paper itself

Abstract

Both RNA synthesis and decay must be balanced within a cell to achieve proper gene expression. Additionally, modulation of RNA decay specifically offers the cell an opportunity to rapidly reshape the transcriptome in response to specific stimuli or cues. Therefore, it is critical to understand the underlying mechanisms through which RNA decay contribute to gene expression homeostasis. Cell-free reconstitution approaches have been used successfully to reveal mechanisms associated with numerous post-transcriptional RNA processes. Historically, it has been difficult to examine all aspects of RNA decay in such an in vitro setting due, in part, to limitations on the ability to resolve larger RNAs through denaturing polyacrylamide gels. Thus, in vitro systems to study RNA decay rely on smaller, less biologically relevant RNA fragments. Herein, we present an approach to more confidently examine RNA decay parameters of large mRNA size transcripts through the inclusion of an engineered XRN1-resistant reporter RNA (xrRNA). By placing a 67 nucleotide xrRNA near the 3' end of any in vitro transcribed RNA with variable size or sequence context, investigators can observe the accumulation of the xrRNA as a readout of exoribonuclease-mediated 5'-3' decay. This approach may allow in vitro RNA decay assays to include full biologically relevant mRNA/mRNPs, extending their utility and allow improved experimental design considerations to promote biologically relevant outcomes.

Indexed as

RNA StabilityCell-Free SystemDenaturing Gradient Gel ElectrophoresisDengue VirusExoribonucleasesGenetic EngineeringGlyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)HumansMicrotubule-Associated ProteinsRNA, MessengerRNA, ViralTranscription, GeneticExoribonucleasesGlyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating)Microtubule-Associated ProteinsRNA, MessengerRNA, ViralXRN1 protein, humanRNA decayRNA stabilityXRN1

Identifiers

PMID30521847
PMCPMC6387842
OpenAlexW2903296661

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.